Overexpression of Mycl, a transcription factor member of a family of oncogenes which was found amplified in ~9% of human SCLC [17] together with the targeted deletion of Rb1 and Trp53 showed an earlier onset of SCLC and shortened latency of tumor development. This evidence concerns the gene TP53 and small cell lung carcinoma.